Sentence examples for patent durations from inspiring English sources

Furthermore, a review of the chemotherapeutic agents developed by the pharmaceutical industry over the past 25 years reveals how despite increased protection in the form of extended patent durations, the industry has not shown a concomitant increase in innovation [ 42].

Pharmaceuticals were considered patentable inventions and patent duration was 10 years (Sec.31(1)).

If patent duration is shortened, consumers will obtain less innovation and less consumer surplus.

Reverse settlements are only problematic under antitrust law if they extend patent duration or scope beyond some baseline.

For expected litigation to be the baseline, one has to assume that Hatch-Waxman modifies patent law and that patent duration after litigation is what is now required.

At the risk of being repetitive (and thereby pedantic), let me restate the conventional tradeoff when setting patent duration, but from the perspective of producer versus consumer surplus as conventional antitrust analysis sees it.

The findings suggest that when market size is small and cumulative innovation is an important phenomenon the policy that extends effective patent duration or subsidizes R&D activity improves incentives to innovate.

There are examples of extension of patent duration beyond the TRIPS commitment of 20 years, under the US Macedonia regional trade Agreement (RTA) where patents on agrochemicals and pharmaceutical products have been increased from 20 to 25 years, and the EU-Morocco RTA where patents on industrial designs were increased from 10 to 15 years.

With respect to pharmaceutical patents, the minimum TRIPS obligations include 20 years of patent protection from the inventor's filing date (Article 33), patent rights free of discrimination against the origin of invention or production (Article 27.1), and exclusive marketing rights for the entire patent duration (Article 28)[ 7].

TRIPS obligations include 20 years of patent protection from the inventor's filing date (Article 33), patent rights free of discrimination against the origin of invention or production (Article 27.1), and exclusive marketing rights for the entire patent duration (Article 28) [ 18].

Neither case concerned the extension of a patent's duration.